The government of Gambia has taken decisive action by dismissing two executives at its Medicines Control Agency (MCA) following the tragic deaths of over 60 children. These deaths were caused by kidney failure resulting from tainted syrup that had been imported from India.
The executive director of the MCA, Markieu Janneh Kaira, has been immediately relieved of his duties, along with the termination of the contract of the deputy executive director. Health Minister Ahmadou Lamin Samateh made the announcement during a briefing in the capital city of Banjul.
The decision to dismiss these officials was based on the recommendations of a presidential inquiry panel, which was formed with the aim of strengthening the MCA and restoring public confidence in the institution. The panel had found evidence that linked the deaths to a specific brand of cough syrup imported from India by Atlantic Pharmaceuticals.
Investigations by Gambia's health authorities indicated that the deaths, which occurred between July last year and January, were likely caused by toxic substances present in the cough syrup. Tests conducted by the World Health Organization confirmed the presence of toxic industrial solvents in four varieties of cheap, over-the-counter syrups manufactured in India by Maiden Pharmaceuticals Ltd.
In addition to their dismissal, the MCA executives may also face prosecution for their alleged failure to fulfil their duties. The presidential panel has recommended that their conduct be further investigated by the Gambia Police Force.
The families of the deceased children have already taken legal action against the Indian company, the Ministry of Health, the MCA, and Atlantic Pharmaceuticals. They are seeking damages of up to $268,000 per child on behalf of the 19 affected families. The case is scheduled to resume in the Banjul High Court in October, following its initial hearing earlier this month.
The dismissal of the MCA executives is a significant step towards addressing the tragedy that has befallen Gambia's children. It is hoped that this action will lead to a thorough investigation and the establishment of more effective measures to prevent such incidents from occurring in the future. The government's commitment to restoring public confidence in the Medicines Control Agency is crucial for ensuring the safety and well-being of the nation's citizens.